The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies

被引：21

作者：

Wang, Weiyuan ^{[1
]}

McDonald, Melanie Cristina Lopez ^{[1
]}

Kim, Christine ^{[1
]}

Ma, Mirielle ^{[1
]}

Pan, Zetao ^{[1
]}

Kaufmann, Charlotte ^{[1
]}

Frank, David A. ^{[1
]}

机构：

[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30307 USA

来源：

FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷

关键词：

cancer; oncology; transcription factors; signal transduction; tumor immunology; protein phosphorylation; RECEPTOR SIGNALING PATHWAYS; IFN-GAMMA; CONSTITUTIVE ACTIVATION; INTERFERON-GAMMA; JAK-STAT; IMMUNE-RESPONSES; GROWTH-FACTOR; CELLS; GENE; TRANSCRIPTION;

D O I：

10.3389/fimmu.2023.1265818

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

STATs are a family of transcription factors that regulate many critical cellular processes such as proliferation, apoptosis, and differentiation. Dysregulation of STATs is frequently observed in tumors and can directly drive cancer pathogenesis. STAT1 and STAT3 are generally viewed as mediating opposite roles in cancer development, with STAT1 suppressing tumorigenesis and STAT3 promoting oncogenesis. In this review, we investigate the specific roles of STAT1 and STAT3 in normal physiology and cancer biology, explore their interactions with each other, and offer insights into therapeutic strategies through modulating their transcriptional activity.

引用

页数：12

共 50 条

[21] The role of STAT1 in tumor killing effect induced by STAT3 inhibition in HNSCC cell lines
Shim, Seon-Hui
Park, Seok-Woo
Sung, Myung-Whun
CANCER RESEARCH, 2006, 66 (08)
[22] Potential roles for STAT1 alpha and STAT3 in the inhibition of erythropoietin-induced erythroid differentiation.
Kirito, K
Uchida, M
Takatoku, M
Nakajima, K
Miura, Y
Komatsu, N
BLOOD, 1997, 90 (10) : 740 - 740
[23] S-glutathionylation exerts opposing roles in the regulation of STAT1 and STAT3 signaling in reactive microglia
Butturini, Elena
Cozzolino, Flora
Boriero, Diana
de Prati, Alessandra Carcereri
Monti, Maria
Rossin, Michele
Canetti, Diana
Cellini, Barbara
Pucci, Piero
Mariotto, Sofia
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 117 : 191 - 201
[24] Simultaneous detection of STAT1, STAT3, and STAT5 activation in response to interferons
Brodey, Mary M.
Zheng, Wei
Wang, Jimin
Reagan, Kevin
CYTOKINE, 2008, 43 (03) : 241 - 241
[25] Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9
Demoulin, JB
Van Roost, E
Stevens, M
Groner, B
Renauld, JC
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) : 25855 - 25861
[26] New insights into the roles of ncRNA in the STAT3 pathway
Zhang, Junxia
Zhang, Anlin
Wang, Yingyi
Liu, Ning
You, Yongping
Kang, Chunsheng
Pu, Peiyu
FUTURE ONCOLOGY, 2012, 8 (06) : 723 - 730
[27] Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking Simulations
Yesylevskyy, Semen O.
Ramseyer, Christophe
Pudlo, Marc
Pallandre, Jean-Rene
Borg, Christophe
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (08) : 1588 - 1596
[28] CTFH CELLS AS DISCRIMINATOR BETWEEN PATIENTS WITH STAT1 AND STAT3 MUTATIONS
Moens, Leen
Schaballie, Heidi
Frans, Glynis
Bosch, Barbara
Schrijvers, Rik
Corveleyn, Anniek
Bossuyt, Xavier
Meyts, Isabelle
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 259 - 259
[29] Measurement of STAT1 and STAT3 phosphorylation by Flow Cytometry and clinical indications
Bitar, M.
Boldt, A.
Binder, S.
Borte, M.
Kentouche, K.
Borte, S.
Sack, U.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 178 - 178
[30] Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
Gordziel, C.
Bratsch, J.
Moriggl, R.
Knoesel, T.
Friedrich, K.
BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 138 - 146

← 1 2 3 4 5 →